Geoffrey Burnstock: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(→‎Talks and interviews: copy edit; added video link)
Line 3: Line 3:


==Talks and interviews==
==Talks and interviews==
*2011, [http://me-pedia.org/wiki/Invest_in_ME_Conference 6th [[Invest in ME International ME Conference]] 2011 ''Purinergic signalling and CNS disorders'']
*2011, [http://me-pedia.org/wiki/Invest_in_ME_Conference 6th [[Invest in ME International ME Conference]] 2011 - Speech Title: ''Purinergic signalling and CNS disorders'']
:*[http://www.investinme.eu/IIMEC6.shtml#dvd 2011 Conference DVD available]
:*[https://www.youtube.com/watch?v=ZWnRxCuKbgo Video of Dr. Burnstock's 2011 presentation]


==Awards==
==Awards==

Revision as of 17:27, December 6, 2017

Source:bioconsulting.co.uk

Geoffrey Burnstock, PhD, (b. 1929) is best known for his discovery that ATP (adenosine triphosphate) is a transmitter in NANC (non-adrenergic, non-cholinergic) nerves and also for the discovery and definition of P2 purinergic receptors, their receptors, their signaling pathways and their functional relevance. He has applied his research to the understanding of pain mechanisms, as well as many other areas not related to ME/CFS.[1]

Talks and interviews[edit | edit source]

Awards[edit | edit source]

  • Australian Academy of Science
  • Royal Academy of Medical Sciences
  • Royal Society Gold medal in 2000
  • President of the International Society for Autonomic Neuroscience (ISAN)

References[edit | edit source]